Anthrax Immune Globulin Intravenous (Human)
| Brand name | Anthrasil |
|---|---|
| Active ingredient | Anthrax Immune Globulin Intravenous (Human) |
| Strength | >=60 U |
| Dosage form | Injection |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | March 2015 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.